Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Information about patients' preference must be obtained first
| The first 150 words of the full text of this article appear below. |
EDITOR
Torgerson and Sibbald discuss the difficulties of assessing the
relative merits of treatments when patients have strong preferences for
one of the alternatives.1 In these circumstances, however,
patients should not be expected to participate in randomised
comparisons, and neither should the professionals caring for them.
It is important to consider the bases of these preferences,
particularly as there is a widespread and unsupported belief that new
treatments are likely to be superior to existing
alternatives.2 For example, it seems that people with
diabetes who were being recruited to a randomised comparison of insulin
pumps with conventional management were left with the impression that
pumps represented an important advance (C Bradley, personal
communication). Not surprisingly, therefore, those allocated to pumps
were pleased, while those allocated to conventional management were
disappointed. Randomisation thus created comparison groups that were
incomparable in these psychological characteristics, and this may have
had implications for